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plant-associated and newly described type strains
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Paul De Vos6, Peter Vandamme6, Jonathan A Eisen7, George Garrity8, Philip Hugenholtz9 and Nikos C Kyrpides2Abstract
The Genomic Encyclopedia of Bacteria and Archaea (GEBA) project was launched by the JGI in 2007 as a pilot
project to sequence about 250 bacterial and archaeal genomes of elevated phylogenetic diversity. Herein, we
propose to extend this approach to type strains of prokaryotes associated with soil or plants and their close
relatives as well as type strains from newly described species. Understanding the microbiology of soil and plants is
critical to many DOE mission areas, such as biofuel production from biomass, biogeochemistry, and carbon cycling.
We are also targeting type strains of novel species while they are being described. Since 2006, about 630 new
species have been described per year, many of which are closely aligned to DOE areas of interest in soil, agriculture,
degradation of pollutants, biofuel production, biogeochemical transformation, and biodiversity.
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The Genomic Encyclopedia of Bacteria and Archaea was
launched in 2007 with the aim of sequencing 250 type
strains from branches of the tree of life with low
sequence representation [1]. The GEBA pilot project,
which encompassed the first 56 genomes, provided con-
vincing evidence of the value of a phylogeny-driven se-
lection of target strains for the discovery of new protein
families and enhancing the accuracy of sequence binning
methods commonly used in metagenome projects [1-4].
In 2012, GEBA was extended with the project entitled
Genomic Encyclopedia of Type Strains, Phase I: the one
thousand microbial genomes project [5]. Major goals
were (i) to demonstrate the value of phylogenetic diver-
sity as a primary criterion for generating genome se-
quences, (ii) to develop the necessary framework,
technology and organization for large-scale sequencing
of microbial genomes, and (iii) to cover as much as
possible of the genomic diversity in the microbial part
of the tree of life. In 2013, a second project entitled
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targeted another 1000 genome sequences and strain se-
lection shifted to complete clusters of all the type strains
in selected genera and small families. This approach was
enabled by the pipeline developed in KMG-I to automate
most steps from sequencing, to annotation, and data de-
position. We note that there has also been an associated
“microbial dark matter” project at DOE-JGI to sequence
the genomes of phylogenetically novel, uncultured taxa
using a single cell whole genome amplification strategy
(see[6]) First results from that project have been published
[7], and it too has moved into its own advanced phase.
This project is not discussed further since our focus is on
cultured organisms.
With the completion of KMG-I expected in the near
future, targets have now been selected for KMG-II se-
quencing. The progress of this effort can be monitored
at the Microbial Earth Project [8]. As of December 2014,
draft or complete genome sequences were available for
1,763 of the 12,239 type strains described (Garrity and
Parker, personal communication). In addition, according
to GOLD sequencing projects were underway for 1,610
strains [9], leaving 8,866 additional type strains without
plans for sequencing in the immediate future. Anticipatingal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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III GEBA project or KMG-III is proposed here to main-
tain the efficiencies of scale and provide a continuous
source of DNA for sequencing of the genomes of micro-
bial type strains.
What are type strains of species and why do we want to
sequence them? By definition, type strains are descendants
of the original isolates that were the basis for species de-
scriptions, as defined by the Bacteriological Code, and
exhibit all of the relevant phenotypic and genotypic
properties cited in the original published taxonomic
circumscriptions [10]. However, their importance in no-
menclature is only one reason for sequencing. By the prin-
ciples of nomenclature, a type strain cannot be identical
with any other type strain. Since 1987, the difference be-
tween type strains has generally been defined in genetic
terms of <70% DNA:DNA hybridization under optimal
conditions and a change in the melting temperature of
hybrid DNAs (ΔTm) of >5 °C [11]. In terms of genomic
sequences, this level of diversity is equivalent to about
69% conserved DNA (or 85% conserved genes) and 95%
average nucleotide identity (ANI) among this conserved
DNA [12,13]. In terms of phenotypic similarity, species
generally possess similarity values as defined by numerical
taxonomy of >70%, which is close to the limit of signifi-
cance [14]. Thus, any two properly described type strains
must be substantially different. For context, if these same
criteria were applied to mammals most primates would be
members of the same species [15]. Of additional import-
ance, virtually all type strains are available in pure culture
(except in the cases of some symbionts and other non-
cultivable species defined prior to the 2001 revisions to
the Bacteriological Code). The implication is that genomic
sequences of type strains will be based upon well-
documented biological specimens that will remain avail-
able for further study for the foreseeable future. Thus, it
will be possible to experimentally verify the sequence
should ambiguities or errors subsequently be identified,
complete draft sequences if new methodologies are devel-
oped, collect additional types of information about the
strains, and experimentally test hypotheses derived from
the genome sequences.
The importance of this research
There are a number of very different but equally valid
reasons to sequence the genomes of type strains.
1) Currently, genomic sequences of cultured organisms
have sampled about 3.6 % of the estimated
phylogenetic diversity of the prokaryotes on earth. If
the genomes of all the known type strains were
sequenced, this sampling is estimated to increase to
about 15% [7]. Given the enormous diversity of
prokaryotes, this is not an insignificant fraction.2) Genomic sequences of type strains will complement
metagenomic and metatranscriptomic sequencing
efforts, which commonly yield large numbers of short
sequences from complex environmental communities.
The genomic sequences of type strains will facilitate
the identification of gene fragments and provide
whole-genome contexts for individual genes.
3) The phenotype and other physiological properties
of type strains are frequently well characterized.
Genomic sequencing of type strains will enable
analyses associating gene content with function,
providing an opportunity to validate genome-based
metabolic reconstructions.
4) Most type strains were described due to their
environmental, medical or commercial importance.
The genomic sequence will provide insights into
the metabolism, stress responses, adaptations to
commensalism, evolution and other processes
important to the role of the microorganism. Thus, it
contributes greatly to our knowledge of the
processes in which these prokaryotes play
fundamental roles.
5) Identification of prokaryotes is still a major
challenge that hinders many practical applications.
Genomic sequencing of type strains will provide the
tools that greatly facilitate identification.
6) The genomes of the type strains will provide the
high resolution data necessary to resolve the
numerous phylogenetic ambiguities limiting
prokaryotic taxonomy.
Lastly, we view this effort as transitional by providing the
support needed to make genome sequencing technology
widely available. As more genomic sequences enter the
public databases, their value will become more apparent to
most investigators and editors of major journals. Given the
anticipated further rapid decreases in cost of sequencing,
we expect that genomic sequences will become a routine
component of the description of new type strains. Thus,
our goal is to place this technology within the reach of a
large group of investigators until it becomes a widely ac-
cepted component of the description of novel species. We
anticipate that once large sequencing projects such as
GEBA have sequenced a significant proportion of the type
strains, community participation will insure that the data-
base of type strain genomic sequences will remain current.
Genomic sequencing is the natural successor of 16S rRNA
sequencing, which was introduced in the description of
type strains over two decades ago and has now become
routine.
Project design
This project focuses on type strains of prokaryotes asso-
ciated with soil or plants and their close relatives as well
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age of microchips and Martian landers, soil is the foun-
dation of civilization. It is the basis for agriculture and
ultimately the source of most food, timber, and other
bioproducts. It contains the largest microbial community
outside our own microbiome with which we are in daily
contact [15,16]. The genomic sequences of prokaryotes
from soil will provide insights into soil fertility, nutrient
cycling, and soil biochemistry. We will also learn more
about how soils mineralize pesticides, produce green-
house gases such as nitrous oxide, or consume green-
house gases like methane. Likewise, plant biomass is the
largest reservoir of living material in the biosphere, far
exceeding the amounts in animals and, very likely,
microorganisms [17]. Understanding the microbiology of
soil and plants is critical to many areas, such as biofuel
production from biomass, biogeochemistry, and carbon
cycling.
We are also proposing the sequencing of type strains
of novel species while they are being described. Since
2006, investigators from around the world have validly
described about 630 new species per year (Figure 1).
Many of these species are closely aligned to areas of
great general interest. An informal survey of the sources
of these new species indicates that about 35% are from
soil or plant-associated. Another 55% are from other
free-living sources, such as seawater, sediments and the
deep subsurface. Many of these include species involved
in degradation of pollutants, biofuel production, biogeo-
chemical transformations, and biodiversity.
With some notable exceptions, genomic sequences are
not part of the descriptions for most of these species.
However, there would be significant value if this were to
change. Therefore, we propose that the genomes ofFigure 1 Cumulative number of prokaryotic species described since
publication of the Approved List in 1980 and 2013. Modified from
Euzéby and Parte [List of Prokaryotic Names with Standing in
Nomenclature: http://www.bacterio.cict.fr/].novel prokaryotes would be sequenced when culture col-
lections issue the Certification of Availability, a step re-
quired for the description of all novel species. This
certificate ensures that the culture is available without
restriction for other investigators. In addition, the collec-
tions routinely ensure that the culture is pure and pos-
sesses properties consistent with those claimed by the
investigator. Because the original investigator will pro-
vide the DNA, access to DNA sequences from type
strains will greatly increase.
Selection of target organisms
We expect that 60% of the target type strains will be se-
lected based on their isolation from soil or plant-
associated material. Closely related strains from the
same genus or family from other non-human sources
will also be included to facilitate comparative analyses.
Type strains from human sources are excluded to avoid
overlap with existing human microbiome projects. How-
ever, it is anticipated that these type strains will be
sequenced by other projects and be available for com-
parative analyses in the near future. The DNA for the
KMG III strains will be mostly provided by the culture
collections working on the project. The remaining 40%
will be type strains from newly described species. The
DNA for these genomes will be solicited directly from
investigators working on these organisms (see below).
We will request proposals for these genome sequencing
projects that will include 1) a justification of how the
project is consistent with the mission of the KMG III
and 2) a copy of the Certificate of Availability, which
demonstrates that the culture has been deposited in an
internationally recognized culture collection. Upon ap-
proval by a committee of the coauthors, the individual
investigators working with these strains will be respon-
sible for providing the DNA and metadata associated
with that organism.
Organism growth and nucleic acid isolation
The culture collections at DSMZ and the ATCC are
partners in GEBA Phase II, and the work proposed here
will be performed in close collaboration with these col-
lections. They will be joined by the China General
Microbiological Culture Collection Center (CGMCC),
which possesses a large collection of type strains isolated
in China, and the Belgian Coordinated Collections of
Microorganisms (BCCM), which has great expertise in
the type strains of plant-associated bacteria. Because
preparation of DNA is now the limiting factor in gen-
ome sequencing and many fastidious organism are not
easily grown by culture collections, individual investiga-
tors will be encourage to submit DNA from laboratory
collections of suitable quality. QC procedures will also
be standardized for individual investigators, and all
Figure 3 Sources of the type strains contributed to the KMG
projects by individual investigators. Others include air, sludge, hot
springs, wall painting, and unknown.
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being shipped to the JGI for sequencing.
A test of the interest by individual investigators was
performed in the spring of 2014. Requests for DNA were
sent to editors of the leading systematics journals and
members of Bergeys International Society for Microbial
Systematics. Proposals to sequence genomes of 589 type
strains were received as of Dec. 1, 2014. Of these, 413
proposals were approved for either GEBA phase II or
phase III sequencing projects. The major reason strains
were not approved was that the sequence was either
completed or in progress elsewhere. Proposals were ap-
proved from 14 countries, which is indicative of large
international participation (Figure 2). About half of the
type strains were plant-associated or from soil or saline
soil, habitats targeted in KMG III (Figure 3). Two
physiological groups were also well represented in this
collection. Strains from saline environments and photo-
trophs represented 18 and 20 % of the type strains, re-
spectively. These groups are of special interest because
of their adaptations to extreme environments and roles
in CO2 fixation.
Sequencing approach
The major sequencing technology developments over
the last years renders a project of this scale not only
technically but also economically feasible. The bulk of
the sequencing will be completed using high throughput
sequencing on the HiSeq Illumina platform. For a subset
of the target strains, Pacific Biosciences single molecule
real time sequencing technology will be used, enabling
the generation of complete or near complete genome
sequences.
The size and nature of the larger user community
As with the other GEBA projects, data will be immedi-
ately released to the public through a variety of channelsFigure 2 Nationalities of the contributors to the GEBA phase II and
III sequencing proposals for the KMG projects. Others include Italy,
Mexico and Portugal.[18,5]. No restrictions will be associated or imposed with
the data release, thus allowing the community to make
immediate and full use of our findings. The grand scale
of the project and the lack of focus on specific applica-
tions will most certainly generate novel information of
broad scientific interest and benefits for the community
at large. Nevertheless, we envision four major stake-
holders within the scientific community with vital inter-
ests in the genomic sequences of type strains covered in
this proposal. First, agricultural researchers will be able
to use these genomes to better understand plant dis-
eases, the transfer of nutrients to and from the plant in
the rhizosphere, and plant symbioses with N2-fixing and
other prokaryotes. Second, for environmental scientists
working in soil and plant systems, these type strains will
provide crucial information for interpreting metage-
nomic and metatranscriptomic data sets encompassing
complex soil and root-associated microbial communities.
Third, for bioinformaticians interested in genome
structure-function relationships, the availability of large
data sets of genomic sequences from phenotypically well
characterized strains will provide new opportunities for
correlating phenotypic traits with genomic sequences
and other functional studies. Lastly, as more genomes
become available for specific groups, the applications of
genome-based systematics will revolutionize the classifi-
cation of prokaryotes [19,20]. Sequences based tools for
the definition of species such as ANI or Genome-to-
Genome-Distance values [13,21,22] will replace the
imprecise and error prone wet lab determinations of
DNA-DNA hybridizations. By providing more reliable
and complete data, it will also allow formation of more
accurate groupings of higher taxa. In addition, it will
provide new insights into the evolution of these prokary-
otic groups through both vertical and horizontal mecha-
nisms of gene transfer.
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for sequencing will provide strong support for DOE mis-
sions in alternative energy production, global carbon se-
questration, and biogeochemistry. Alternative energy
production, especially biofuel production from biomass,
relies heavily on improved and more efficient agriculture
to produce inexpensive biomass. Genomic sequencing
will contribute to alternative energy production by fur-
thering our understanding of soil fertility, biotransforma-
tions of herbicides and pesticides, bacterial diseases of
plants, and practical questions in crop management.
Similarly, genomic sequencing of plant-associated pro-
karyotes will provide insights into basic questions in
plant-prokaryotic symbioses as well as potential applica-
tions in N2-fixation and nutrient assimilation. Soil and
plants contain 1500 Pg and 560 Pg of carbon, respect-
ively, compared to 750 Pg of carbon in the earth’s atmos-
phere (1 Pg = 1015 g). Given the enormity of these
reservoirs, they are important sources and sinks of inor-
ganic and organic carbon.
Genomic sequencing of type strains from soil will pro-
vide insights into many of the carbon fluxes from soil.
Of special interest are processes and enzymes for deg-
radation of recalcitrant organic compounds, methane-
oxidizing bacteria, and CO2-fixation among soil
autotrophs such as nitrifiers. Because soil is a sink for at-
mospheric CO2 and CH4 as well as a source for the
greenhouse gas N2O, insight into these processes is ex-
pected as well. Genomic sequencing of plant-associated
type strains will provide insights into processes such as
sequestration of newly fixed plant organic carbon by soil
microorganisms and mineralization or degradation of
complex plant polymers. Finally, soil is a major repository
for toxic metals, radionucleotides and organic contami-
nants. Genomic sequencing of type strains from soil will
provide insight into the microbial responses to these com-
pounds, better informing the decision-making process for
environmental remediation and providing a mechanistic
understanding of bioremediation.
Conclusion
Phase III of the GEBA project demonstrates that it is
possible to obtain significant assistance in the genome
sequencing of type strains from the international com-
munity of bacteriologists. Experts in individual taxa are
willing to provide DNA from the type strains in their la-
boratory collections for sequencing at JGI. The genome
sequences provide these experts great insights into ques-
tions specific to their organisms as well as those of inter-
est to the broader community of prokaryotic biologists.
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